Xinchen Ke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xinchen Ke has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Juan Su
Department of Dermatology Xiangya Hospital, Central South University Changsha China
2 shared publications - Guiyun Gao
Department of Dermatology, Hunan Aerospace Hospital, Changsha 410205, China
1 shared publication Mi Zhang
Department of Dermatology, Xiangya Hospital, Central South University , Changsha , China
1 shared publication- Mingliang Chen
Department of Dermatology
1 shared publication Minxue Shen
Department of Dermatology, Xiangya Hospital, Central South University , Changsha , China
1 shared publication- Minxue Shen
Department of Social Medicine and Health Management, Xiangya School of Public Health, Central South University, Changsha, China
1 shared publication
Latest Publications
- Open Access
- 12 November 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (22) , 14916
Delay in Seeking Medical Attention and Diagnosis in Chinese Melanoma Patients: A Cross-Sectional Study
Melanoma is a highly malignant skin tumor, and prolonged delay in seeking medical attention (DSMA) and delay in diagnosis (DD) may result in poor prognoses. Through a web-based questionnaire, we explored the related factors affecting the DSMA and DD of melanoma in a Chinese population. A total of 112 valid answer sheets were received. After obtaining the relevant information, we analyzed the factors associated with DSMA and DD. The median time of DSMA was 8.0 (quartiles: 1.0, 29.3) months, and the median of patients’ DD was 1.0 (quartiles: 1.0, 8.3) month. The subsequent analysis showed that DSMA and DD were positively correlated to age and negatively correlated to education background and annual household income. Patients with a history of tumors or previous health-seeking behavior because of other skin lesions had significantly longer DSMA than those without. Patients who sought medical help at general tertiary hospitals for the first time had a significantly shorter DD than those who chose other hospitals. Our study found that DSMA and DD are associated with factors such as age, education, income, and patients’ histories. Secondary prevention of Chinese melanoma should be strengthened to reduce DSMA and DD to improve patients’ prognoses.
- 12 November 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (22) , 14916
Open AccessDelay in Seeking Medical Attention and Diagnosis in Chinese Melanoma Patients: A Cross-Sectional Study
Melanoma is a highly malignant skin tumor, and prolonged delay in seeking medical attention (DSMA) and delay in diagnosis (DD) may result in poor prognoses. Through a web-based questionnaire, we explored the related factors affecting the DSMA and DD of melanoma in a Chinese population. A total of 112 valid answer sheets were received. After obtaining the relevant information, we analyzed the factors associated with DSMA and DD. The median time of DSMA was 8.0 (quartiles: 1.0, 29.3) months, and the median of patients’ DD was 1.0 (quartiles: 1.0, 8.3) month. The subsequent analysis showed that DSMA and DD were positively correlated to age and negatively correlated to education background and annual household income. Patients with a history of tumors or previous health-seeking behavior because of other skin lesions had significantly longer DSMA than those without. Patients who sought medical help at general tertiary hospitals for the first time had a significantly shorter DD than those who chose other hospitals. Our study found that DSMA and DD are associated with factors such as age, education, income, and patients’ histories. Secondary prevention of Chinese melanoma should be strengthened to reduce DSMA and DD to improve patients’ prognoses.
- 30 September 2021
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 28 (2) , e27-e28
Association Between Inflammatory Bowel Disease and Atopic Dermatitis: A Two-Sample Mendelian Randomization Study
To The Editors, Inflammatory bowel disease (IBD) is a type of idiopathic inflammatory disease including Crohn’s disease and ulcerative colitis. Atopic dermatitis (AD) is a common inflammatory skin disorder. Recent studies indicated that the incidence and prevalence of IBD and AD are strongly related,1 and a bidirectional relationship was found through a meta-analysis.2 Mendelian randomization (MR) is an excellent method that uses genetic variants as instrumental variables to assess causal relationships between chronic diseases. Here, we performed a 2-sample MR analysis for the association between IBD and AD. The raw data were collected from OpenGWAS database (https://gwas.mrcieu.ac.uk/). For IBD, we extracted the result of an analysis by Liu et al from 9 GWAS studies with 34,652 subjects to generate the instrumental variables (IVs; ieu-a-31).3 For AD, the data by Ishigaki et al from 28 GWAS studies with 212,036 subjects were used in the exposure datasheet (bbj-a-90).4 The R package “TwoSampleMR” was performed for analysis and followed the guidelines (https://mrcieu.github.io/TwoSampleMR).
- 30 September 2021
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 28 (2) , e27-e28
Association Between Inflammatory Bowel Disease and Atopic Dermatitis: A Two-Sample Mendelian Randomization Study
To The Editors, Inflammatory bowel disease (IBD) is a type of idiopathic inflammatory disease including Crohn’s disease and ulcerative colitis. Atopic dermatitis (AD) is a common inflammatory skin disorder. Recent studies indicated that the incidence and prevalence of IBD and AD are strongly related,1 and a bidirectional relationship was found through a meta-analysis.2 Mendelian randomization (MR) is an excellent method that uses genetic variants as instrumental variables to assess causal relationships between chronic diseases. Here, we performed a 2-sample MR analysis for the association between IBD and AD. The raw data were collected from OpenGWAS database (https://gwas.mrcieu.ac.uk/). For IBD, we extracted the result of an analysis by Liu et al from 9 GWAS studies with 34,652 subjects to generate the instrumental variables (IVs; ieu-a-31).3 For AD, the data by Ishigaki et al from 28 GWAS studies with 212,036 subjects were used in the exposure datasheet (bbj-a-90).4 The R package “TwoSampleMR” was performed for analysis and followed the guidelines (https://mrcieu.github.io/TwoSampleMR).